share_log

普利制药:关于关于碘帕醇注射液(血管内给药)新增规格的补充申请获得美国食品药品监督管理局(FDA)上市许可的公告

Puri Pharmaceuticals: Notice on the US Food and Drug Administration (FDA) marketing approval for a supplementary application for new specifications for iopamol injections (intravascular administration)

深证信a股 ·  Apr 11
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more